---
title: Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular
  carcinoma by reprogramming glutamine metabolism
date: '2024-03-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38450598/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240307170638&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: SLC25A15 is hypoxia-responsive in HCC, and low SLC25A15
  levels result in glutamine reprogramming through SLC1A5 and OGDHL regulation, promoting
  HCC progression and regulating cell sensitivity to anti-PD-L1. Interrupting the
  glutamine-derived energy supply is a potential therapeutic strategy for treating
  SLC25A15-deficient ...'
disable_comments: true
---
CONCLUSION: SLC25A15 is hypoxia-responsive in HCC, and low SLC25A15 levels result in glutamine reprogramming through SLC1A5 and OGDHL regulation, promoting HCC progression and regulating cell sensitivity to anti-PD-L1. Interrupting the glutamine-derived energy supply is a potential therapeutic strategy for treating SLC25A15-deficient ...